41 results
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
1 Dec 22
Maravai LifeSciences Announces Updated CEO Leadership Transition Plans
4:26pm
placement on a paid leave of absence as a result of a lawsuit claiming violation of a noncompetition agreement filed by two of Martin’s former … Production Segment through July 26, 2023. The parties also agreed to voluntarily dismiss the lawsuit.
“We are thrilled to have Trey rejoin Maravai’s
8-K
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
1 Dec 22
Maravai LifeSciences Announces Updated CEO Leadership Transition Plans
4:26pm
, as a result of a lawsuit claiming violation of a noncompetition agreement filed by two of Martin’s former employers, subsidiaries of Danaher … segment through July 26, 2023. The parties also agreed to voluntarily dismiss the lawsuit.
Item 7.01.
Regulation FD Disclosure
On December 1, 2022
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
19 Oct 22
Departure of Directors or Certain Officers
4:05pm
, two of which previously employed recently-appointed Maravai CEO William “Trey” Martin, III, have filed a lawsuit against Martin and Maravai
8-K
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
19 Oct 22
Departure of Directors or Certain Officers
4:05pm
of Chancery preventing him from working for the Company pending further order of the Court in a lawsuit filed against him by his previous employer
8-K
EX-10.10
2bkdb 5pt
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.8
y9oc6ynm20af iw6ety
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.9
abxupanpo7in 1nh
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.1
9e7b1dglo0vwtr5
3 Oct 22
Maravai LifeSciences Announces CEO Leadership Transition
4:07pm
10-K
EX-4.2
usjwko7yumbblb5qp
22 Mar 21
Annual report
4:22pm